SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharma - Quaterly Results

22 Jul 2022 Evaluate
The revenue for the June 2022 quarter is pegged at Rs. 0.00 millions against Rs. 23.41 millions recorded during the year-ago period.The Net Loss for the quarter ended June 2022 is Rs. -1.43 millions as compared to Net Profit of Rs. 0.10 millions of corresponding quarter ended June 2021Operating profit Margin for the quarter ended June 2022 slipped to -0.55% as compared to 0.46% of corresponding quarter ended June 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 0.00 23.41 0.00 0.00 23.41 0.00 39.39 85.51 -53.94
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.26 -42.31
PBIDT -0.55 0.46 -219.57 -0.55 0.46 -219.57 1.52 1.33 14.29
Interest 0.03 0.00 0.00 0.03 0.00 0.00 0.03 0.00 0.00
PBDT -0.58 0.46 -226.09 -0.58 0.46 -226.09 1.49 1.33 12.03
Depreciation 0.00 0.04 0.00 0.00 0.04 0.00 0.09 0.45 -80.00
PBT -0.58 0.42 -238.10 -0.58 0.42 -238.10 1.40 0.88 59.09
TAX 0.85 0.32 165.63 0.85 0.32 165.63 -0.05 -0.05 0.00
Deferred Tax 0.85 0.32 165.63 0.85 0.32 165.63 -0.05 -0.05 0.00
PAT -1.43 0.10 -1530.00 -1.43 0.10 -1530.00 1.45 0.93 55.91
Equity 103.11 103.11 0.00 103.11 103.11 0.00 102.69 102.69 0.00
PBIDTM(%) 0.00 1.96 0.00 0.00 1.96 0.00 3.86 1.56 148.09

Pharmaids Pharma Share Price

30.92 -0.49 (-1.56%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×